Abstract
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are used to treat acute pulmonary embolism (PE). However, lower NOAC doses are often p......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
